Risk factors for candidemia in non-neutropenic critical patients in Colombia

Med Intensiva. 2016 Apr;40(3):139-44. doi: 10.1016/j.medin.2015.08.001. Epub 2015 Dec 25.
[Article in English, Spanish]

Abstract

Objectives: Due to the increase in isolation of Candida spp. in critically ill patients, and the high mortality and economic costs which this infection entails, a study was made of the risk factors associated to candidemia in critically ill patients from 7 intensive care units in Colombia.

Materials and methods: A multicenter matched case-control study was conducted in 7 intensive care units of 3 university hospitals. Data on overall length of hospital stay (including both general wards and the intensive care unit) were recorded.

Results: A total of 243 subjects (81 cases and 162 controls) between January 2008 and December 2012 were included. In order of frequency, C. albicans, C. tropicalis and C. parapsilosis were isolated. The main identified risk factors were: overall length of hospital stay>25 days (OR 5.33, 95% CI 2.6-10.9), use of meropenem (OR 3.75, 95% CI 1.86-7.5), abdominal surgery (OR 2.9, 95% CI 1.39-6.06) and hemodialysis (OR 3.35, 95% CI 1.5-7.7). No differences in mortality between patients with candidemia and controls were found (39.5 vs. 36.5%, respectively, P=.66) were found.

Conclusions: In Colombia, a long hospital stay, abdominal surgery, the use of meropenem and hemodialysis were identified as risk factors for candidemia.

Keywords: Candida; Candidiasis invasiva; Cuidado intensivo; Factores de riesgo; Intensive care; Invasive candidiasis; Mortalidad; Mortality; Risk factors.

MeSH terms

  • Antifungal Agents / therapeutic use
  • Candidemia / etiology*
  • Candidiasis / drug therapy
  • Candidiasis / etiology*
  • Case-Control Studies
  • Colombia
  • Critical Illness*
  • Cross Infection
  • Humans
  • Incidence
  • Length of Stay
  • Risk Factors

Substances

  • Antifungal Agents